| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.01 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.01 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |